Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07447843 · ClinicalTrials.gov registry record · NA
Safety and Tolerability of a Nutritional Formula Designed to Aid in Maintenance of Muscle During Periods of Caloric Restriction in Adults
A NA study, sponsored by Nature's Sunshine Products.
- Not yet
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT07447843 is a NA study that has not yet begun recruiting, run by Nature's Sunshine Products. The registered enrollment target is 80 participants.
The verdict
NCT07447843, a NA study, has not yet begun recruiting, sponsored by Nature's Sunshine Products.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Muscle loss during caloric restriction is a significant concern for metabolic health and physical function, yet there is limited evidence on interventions that simultaneously target multiple contributing pathways. This study investigates a multi-component formulation targeting these complementary pathways to address critical gaps in strategies for preserving lean mass during energy restriction. The primary goal of this study is to demonstrate the safety and tolerability of the product Redefine when used as an adjunct to a well-established caloric restriction regimen. Caloric restriction is known to result in unintended loss of skeletal muscle mass, which may negatively impact physical function and metabolic health. This study seeks to evaluate whether supplementation with Redefine may help preserve muscle mass and support the maintenance of healthy muscle function during caloric restriction. Secondarily, this study aims to explore whether Redefine supplementation may confer favorable changes in body composition in subjects participating in a caloric restriction regimen. This product consists of HMB, postbiotics and botanicals.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Redefine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-04 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07447843
The ClinicalTrials.gov registry entry for NCT07447843 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nature's Sunshine Products, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07447843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07447843 about?
NCT07447843 is a clinical study titled "Safety and Tolerability of a Nutritional Formula Designed to Aid in Maintenance of Muscle During Periods of Caloric Restriction in Adults". Muscle loss during caloric restriction is a significant concern for metabolic health and physical function, yet there is limited evidence on interventions that simultaneously target multiple contributing pathways. This study investigates a multi-component formulation targeting these complementary pa...
What is the current status of trial NCT07447843?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-04. Estimated completion is 2026-10.
What interventions are being tested in trial NCT07447843?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Redefine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07447843?
This trial is sponsored by Nature's Sunshine Products, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.